Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer

IMPORTANCE: There is a need to identify prognostic biomarkers to guide treatment intensification in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC). OBJECTIVE: To examine whether molecular subtypes predict response to apalutamide, using archived primary tumor samples from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Felix Y., Thomas, Shibu, Saad, Fred, Gormley, Michael, Yu, Margaret K., Ricci, Deborah S., Rooney, Brendan, Brookman-May, Sabine, McCarthy, Sharon, Olmos, David, Chowdhury, Simon, Hadaschik, Boris, Liu, Yang, Davicioni, Elai, Smith, Matthew R., Small, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176389/
https://www.ncbi.nlm.nih.gov/pubmed/34081076
http://dx.doi.org/10.1001/jamaoncol.2021.1463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176389/
https://www.ncbi.nlm.nih.gov/pubmed/34081076
http://dx.doi.org/10.1001/jamaoncol.2021.1463

Ejemplares similares